Further, we observed a positive correlation between Ki67 immunostaining and androgen signaling in bicalutamide‐treated PDEs, consistent with the effect of bicalutamide on prostate tumor PDE proliferation being AR‐mediated. The gene discussed is MKI67; the disease is prostate neoplasm.